ArticleAmerican journal of cancer research2016

ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.

Meenu Madan et al.PubMed ↗Full text ↗

No numbers read from the abstract.